Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
32.96
+0.06 (0.18%)
Mar 14, 2025, 4:00 PM EST - Market closed
Ionis Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Net Income | -453.9 | -366.29 | -269.72 | -28.6 | -444.26 | Upgrade
|
Depreciation & Amortization | 21.99 | 22.5 | 22.11 | 19.56 | 17.16 | Upgrade
|
Other Amortization | 6.69 | 6.33 | 5.37 | 4.96 | 3.26 | Upgrade
|
Loss (Gain) From Sale of Assets | 10.44 | 18.47 | -147.57 | 2.71 | 1.95 | Upgrade
|
Loss (Gain) From Sale of Investments | -34.84 | -27.3 | 7.61 | 16.68 | -5.02 | Upgrade
|
Stock-Based Compensation | 130.2 | 105.81 | 100.26 | 120.68 | 230.12 | Upgrade
|
Other Operating Activities | 27.87 | 10.22 | - | 8.63 | 306.25 | Upgrade
|
Change in Accounts Receivable | 5.59 | -72.06 | 36.36 | 14.31 | -13.17 | Upgrade
|
Change in Inventory | -5.07 | -2.47 | 5.33 | -2.84 | -1.26 | Upgrade
|
Change in Accounts Payable | 15.99 | 8.12 | 1.09 | -6 | -2.76 | Upgrade
|
Change in Unearned Revenue | -156.82 | 13.97 | -71.25 | -82.83 | -75.91 | Upgrade
|
Change in Income Taxes | -2.12 | -4.1 | 6.21 | -0.28 | -31.28 | Upgrade
|
Change in Other Net Operating Assets | -66.96 | -20.72 | 29.83 | -36.18 | 50.82 | Upgrade
|
Operating Cash Flow | -500.95 | -307.51 | -274.37 | 30.8 | 35.89 | Upgrade
|
Operating Cash Flow Growth | - | - | - | -14.19% | -89.62% | Upgrade
|
Capital Expenditures | -45.28 | -23.81 | -15.72 | -11.96 | -35.12 | Upgrade
|
Sale (Purchase) of Intangibles | -5.06 | -4.21 | -4.38 | -5.95 | -5.93 | Upgrade
|
Investment in Securities | -83.69 | -186.14 | -496.62 | 212.81 | 315.53 | Upgrade
|
Investing Cash Flow | -134.03 | -214.13 | -262.64 | 194.91 | 274.48 | Upgrade
|
Long-Term Debt Issued | - | 575 | - | 632.5 | - | Upgrade
|
Long-Term Debt Repaid | -44.67 | -488.1 | -50.69 | -318.93 | - | Upgrade
|
Net Debt Issued (Repaid) | -44.67 | 86.9 | -50.69 | 313.57 | - | Upgrade
|
Issuance of Common Stock | 522.73 | 49.44 | 6.37 | 11.57 | 52.04 | Upgrade
|
Repurchase of Common Stock | - | - | -10.95 | -16.73 | -103.96 | Upgrade
|
Other Financing Activities | - | 507.74 | -0.03 | -62.48 | -544.69 | Upgrade
|
Financing Cash Flow | 478.06 | 644.08 | -55.3 | 245.93 | -596.61 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.27 | 0.35 | -0.42 | -0.11 | 0.62 | Upgrade
|
Net Cash Flow | -157.19 | 122.79 | -592.72 | 471.53 | -285.62 | Upgrade
|
Free Cash Flow | -546.23 | -331.32 | -290.09 | 18.84 | 0.77 | Upgrade
|
Free Cash Flow Growth | - | - | - | 2340.93% | -99.75% | Upgrade
|
Free Cash Flow Margin | -77.46% | -42.06% | -49.39% | 2.33% | 0.11% | Upgrade
|
Free Cash Flow Per Share | -3.65 | -2.31 | -2.05 | 0.13 | 0.01 | Upgrade
|
Cash Interest Paid | 10.87 | 6.51 | 2.9 | 4.78 | 6.25 | Upgrade
|
Cash Income Tax Paid | -5.62 | 48.33 | 5.01 | 0.04 | 25.86 | Upgrade
|
Levered Free Cash Flow | -352.83 | -161.03 | -80.22 | 76.54 | 88.04 | Upgrade
|
Unlevered Free Cash Flow | -302.98 | -116.45 | -80.51 | 77.42 | 90.73 | Upgrade
|
Change in Net Working Capital | 107.91 | 8.16 | -73.59 | 26.05 | 7.95 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.